| Product Name |
Lapatinib Inhouse Impurity 4 / Deschloro Lapatinib
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Metabolites, Pharmaceutical Standards, Fine Chemicals |
| CAS No |
633370-23-7 |
| Catalog Number |
GS.08.LAP.34 |
| Chemical Name/Synonyms |
N-(4-((3-Fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine ; N-[4-[(3-Fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine |
| Molecular Weight |
546.62 |
| Molecular Formula |
C29H27FN4O4S |
| Purity |
NLT 95 % |
| Applications |
Lapatinib is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy. |
| Inventory Status |
customized
|
